L&T report its #Q1 earnings;
▶️Net Profit At ₹3,617 Cr Vs CNBC-TV18 Poll Of ₹3,387 Cr
▶️Revenue At ₹63,678 Cr Vs CNBC-TV18 Poll Of ₹62,829 Cr
▶️EBITDA At ₹6,316 Cr Vs CNBC-TV18 Poll Of ₹6,362 Cr
▶️Margin At 9.9% Vs CNBC-TV18 Poll Of 10.1%
▶️Net Profit At ₹3,617 Cr Vs CNBC-TV18 Poll Of ₹3,387 Cr
▶️Revenue At ₹63,678 Cr Vs CNBC-TV18 Poll Of ₹62,829 Cr
▶️EBITDA At ₹6,316 Cr Vs CNBC-TV18 Poll Of ₹6,362 Cr
▶️Margin At 9.9% Vs CNBC-TV18 Poll Of 10.1%
#EmcurePharma reports its #Q1 earnings:
👉Net Profit Up 44% At ₹207 Cr Vs ₹144 Cr (YoY)
👉Revenue Up 15.7% At ₹2,100 Cr Vs ₹1,815 Cr (YoY)
👉EBITDA Up 24% At ₹417 Cr Vs ₹336.4 Cr (YoY)
👉Margin At 20% Vs 18.5% (YoY)
👉Net Profit Up 44% At ₹207 Cr Vs ₹144 Cr (YoY)
👉Revenue Up 15.7% At ₹2,100 Cr Vs ₹1,815 Cr (YoY)
👉EBITDA Up 24% At ₹417 Cr Vs ₹336.4 Cr (YoY)
👉Margin At 20% Vs 18.5% (YoY)
Godrej Cons report #Q1Results;
👉Net Profit At ₹452.5 Cr Vs ₹480 Cr
👉Revenue At ₹3,662 Cr Vs ₹3,665 Cr
👉EBITDA At ₹694.8 Cr Vs ₹739 Cr
👉Margin At 19% Vs 20.2%
👉Net Profit At ₹452.5 Cr Vs ₹480 Cr
👉Revenue At ₹3,662 Cr Vs ₹3,665 Cr
👉EBITDA At ₹694.8 Cr Vs ₹739 Cr
👉Margin At 19% Vs 20.2%
RITES reports #Q1results
Net profit up 0.7% at ₹91 cr vs ₹90.4 cr (YoY)
Revenue up 0.8% at ₹489.7 cr vs ₹485.8 cr (YoY)
EBITDA up 7.8% at ₹114 cr vs ₹106 cr (YoY)
Margin at 23.3% vs 21.8% (YoY)
Net profit up 0.7% at ₹91 cr vs ₹90.4 cr (YoY)
Revenue up 0.8% at ₹489.7 cr vs ₹485.8 cr (YoY)
EBITDA up 7.8% at ₹114 cr vs ₹106 cr (YoY)
Margin at 23.3% vs 21.8% (YoY)
💎#BayerCrop
reports its #Q1 earnings:
👉Net Profit Up 9.6% At ₹278.7 Cr Vs ₹254 Cr (YoY)
👉Revenue Up 17.4% At ₹1,914.6 Cr Vs ₹1,631.4 Cr (YoY)
👉EBITDA Up 11% At ₹348.5 Cr Vs ₹314 Cr (YoY)
👉Margin At 18.2% Vs 19.3% (YoY)
reports its #Q1 earnings:
👉Net Profit Up 9.6% At ₹278.7 Cr Vs ₹254 Cr (YoY)
👉Revenue Up 17.4% At ₹1,914.6 Cr Vs ₹1,631.4 Cr (YoY)
👉EBITDA Up 11% At ₹348.5 Cr Vs ₹314 Cr (YoY)
👉Margin At 18.2% Vs 19.3% (YoY)
❤1